NCT07511985

Brief Summary

This prospective observational study aims to evaluate whether rebound pain after peripheral nerve block is associated with the development of chronic postsurgical pain following elective total knee arthroplasty. Adult patients undergoing unilateral total knee arthroplasty under spinal anesthesia and receiving a peripheral nerve block as part of routine multimodal analgesia will be included. No additional intervention, drug administration, or biological sampling will be performed beyond standard clinical care. Rebound pain will be assessed during the early postoperative period using pain diaries, numeric rating scale pain scores, and analgesic consumption records. Chronic postsurgical pain and related outcomes will be evaluated at postoperative 3 and 6 months using validated instruments assessing pain severity, neuropathic pain features, psychological status, functional outcomes, and health-related quality of life. The primary outcome is the presence of chronic postsurgical pain at 3 months after surgery. Secondary outcomes include chronic pain at 6 months, pain intensity, neuropathic pain characteristics, opioid consumption, rescue analgesic requirements, sleep disturbance, and quality-of-life measures. The study also aims to explore demographic and clinical factors associated with rebound pain and chronic postsurgical pain.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Apr 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

March 30, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 6, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

March 30, 2026

Last Update Submit

April 5, 2026

Conditions

Keywords

rebound painchronic postsurgical paintotal knee arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Presence of Chronic Postsurgical Pain at 3 Months

    Chronic postsurgical pain will be defined as pain developing or persisting after total knee arthroplasty that is not explained by another cause. Participants with pain and at least one Brief Pain Inventory-Short Form interference item score of 3 or higher at postoperative month 3 will be considered positive for chronic postsurgical pain.

    3 months after surgery

Secondary Outcomes (2)

  • Presence of Chronic Postsurgical Pain at 6 Months assessed by Brief Pain Inventory-Short Form (BPI-SF) interference score

    6 months after surgery

  • Pain Intensity in the Early Postoperative Period

    0 to 72 hours after surgery

Study Arms (2)

Rebound Pain

Participants with a transition from well-controlled pain (Numeric Rating Scale \[NRS\] \<=3) to severe pain (NRS \>=7) within 0 to 48 hours after peripheral nerve block resolution.

No Rebound Pain

Participants without a transition from well-controlled pain (Numeric Rating Scale \[NRS\] \<=3) to severe pain (NRS \>=7) within 0 to 48 hours after peripheral nerve block resolution.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing unilateral elective total knee arthroplasty at Konya City Hospital under spinal anesthesia and receiving a peripheral nerve block as part of routine multimodal analgesia.

You may qualify if:

  • Age 18 years or older
  • ASA physical status I to III
  • Scheduled for unilateral elective total knee arthroplasty
  • Planned to undergo spinal anesthesia
  • Planned to receive a peripheral nerve block as part of routine multimodal analgesia
  • Able to provide informed consent and complete study assessments

You may not qualify if:

  • Chronic opioid use (60 mg oral morphine equivalent per day or more, or use for 3 months or longer)
  • Significant neuropathy or radiculopathy
  • Bilateral or two-stage total knee arthroplasty during the same hospitalization
  • Contralateral total knee arthroplasty within the previous 6 months
  • Severe cognitive impairment or major psychiatric disorder
  • Chronic analgesic dependence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, PostoperativeChronic Pain

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Mahmut Tutar, MD

    KONYA CITY HOSPİTAL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmut Tutar, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Anesthesiology and Reanimation

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 6, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

December 12, 2026

Study Completion (Estimated)

December 12, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share